Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quan Fang

Showing results (241-250 of 363) with videos related to

Pageof 37
Sort By:
Frontiers in Molecular Biosciences|August 13, 2021
Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic SimulationYaoqiang Du, Hao Wang, Linjie Chen, et al.
Behavioural Brain Research|April 13, 2013
Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in miceZheng-lan Han, Zi-long Wang, Hong-zhu Tang, et al.
Acta Cardiologica Sinica|April 29, 2016
Six-Minute Walking Test: Normal Reference Values for Taiwanese Children and AdolescentsChun-An Chen, Chin-Hao Chang, Ming-Tai Lin, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 12, 2017
Association Between Oxidative Stress and Peripheral Leukocyte Telomere Length in Patients with Premature Coronary Artery DiseaseRan Tian, Lei-Nan Zhang, Ting-Ting Zhang, et al.
Cancer Science|July 4, 2023
N<sup>6</sup> -methyladenosine-modified FAM111A-DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111AJian Pu, Zuoming Xu, Youguan Huang, et al.
ACS Nano|December 27, 2022
Biomimetic Nanosonosensitizers Combined with Noninvasive Ultrasound Actuation to Reverse Drug Resistance and Sonodynamic-Enhanced Chemotherapy against Orthotopic GlioblastomaHuaqing Chen, Shengping Zhang, Quan Fang, et al.
European Journal of Pharmacology|May 17, 2020
Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesiaRun Zhang, Biao Xu, Qinqin Zhang, et al.
ACS Chemical Neuroscience|October 20, 2022
OFP011 Cyclic Peptide as a Multifunctional Agonist for Opioid/Neuropeptide FF Receptors with Improved Blood-Brain Barrier PenetrationMengna Zhang, Biao Xu, Ning Li, et al.
Cancer Medicine|January 5, 2023
Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphomaChieh-Lung Cheng, Po-Ting Yeh, Wei-Quan Fang, et al.
Journal of Medicinal Chemistry|September 1, 2021
Development of Multifunctional and Orally Active Cyclic Peptide Agonists of Opioid/Neuropeptide FF Receptors that Produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side EffectsMengna Zhang, Biao Xu, Ning Li, et al.
Pageof 37

Showing results (241-250 of 363) with videos related to

Sort By:
Pageof 37
Frontiers in Molecular Biosciences|August 13, 2021
Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic SimulationYaoqiang Du, Hao Wang, Linjie Chen, et al.
Behavioural Brain Research|April 13, 2013
Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in miceZheng-lan Han, Zi-long Wang, Hong-zhu Tang, et al.
Acta Cardiologica Sinica|April 29, 2016
Six-Minute Walking Test: Normal Reference Values for Taiwanese Children and AdolescentsChun-An Chen, Chin-Hao Chang, Ming-Tai Lin, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 12, 2017
Association Between Oxidative Stress and Peripheral Leukocyte Telomere Length in Patients with Premature Coronary Artery DiseaseRan Tian, Lei-Nan Zhang, Ting-Ting Zhang, et al.
Cancer Science|July 4, 2023
N<sup>6</sup> -methyladenosine-modified FAM111A-DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111AJian Pu, Zuoming Xu, Youguan Huang, et al.
ACS Nano|December 27, 2022
Biomimetic Nanosonosensitizers Combined with Noninvasive Ultrasound Actuation to Reverse Drug Resistance and Sonodynamic-Enhanced Chemotherapy against Orthotopic GlioblastomaHuaqing Chen, Shengping Zhang, Quan Fang, et al.
European Journal of Pharmacology|May 17, 2020
Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesiaRun Zhang, Biao Xu, Qinqin Zhang, et al.
ACS Chemical Neuroscience|October 20, 2022
OFP011 Cyclic Peptide as a Multifunctional Agonist for Opioid/Neuropeptide FF Receptors with Improved Blood-Brain Barrier PenetrationMengna Zhang, Biao Xu, Ning Li, et al.
Cancer Medicine|January 5, 2023
Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphomaChieh-Lung Cheng, Po-Ting Yeh, Wei-Quan Fang, et al.
Journal of Medicinal Chemistry|September 1, 2021
Development of Multifunctional and Orally Active Cyclic Peptide Agonists of Opioid/Neuropeptide FF Receptors that Produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side EffectsMengna Zhang, Biao Xu, Ning Li, et al.
Pageof 37